Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endo International PLC (NASDAQ:ENDP)

20.15
Delayed Data
As of 4:00pm ET
 -0.78 / -3.73%
Today’s Change
12.56
Today|||52-Week Range
72.85
-67.09%
Year-to-Date
Better Buy: Valeant Pharmaceuticals International, Inc. vs. Endo International plc
8:06am / MotleyFool.com - Paid Partner Content
Why Twitter, Endo International, and Hyster-Yale Materials Handling Jumped Today
Sep 23 / MotleyFool.com - Paid Partner Content
Endo (ENDP) Stock Slumps, Oppenheimer: 'Not Surprised' by CEO Change
Sep 26 / TheStreet.com - Paid Partner Content
Why Endo International plc Jumped Higher Today
Sep 23 / MotleyFool.com - Paid Partner Content
Endo Appoints New CEO, Keeps Q3 & '16 View, Stock Jumps
Sep 26 / Zacks.com - Paid Partner Content
Drugmaker Endo rises on leadership change
Sep 23 / FT.com - Paid Partner Content
Company News for September 26, 2016
Sep 26 / Zacks.com - Paid Partner Content
Endo (ENDP) Stock Soars After Campanelli Named CEO
Sep 23 / TheStreet.com - Paid Partner Content
Changes at the Top for Endo Could Benefit Its Smaller Partners
Sep 26 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close20.93
Today’s open20.97
Day’s range20.05 - 21.03
Volume11,686,505
Average volume (3 months)7,550,313
Market cap$4.7B
Dividend yield--
Data as of 4:00pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-55.88%
Earnings growth (this year)-2.15%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)+13.61%
P/E ratioNM
Price/Sales3.69
Price/Book0.78

Competitors

 Today’s
change
Today’s
% change
TAROTaro Pharmaceutical ...-2.88-2.54%
UTHRUnited Therapeutics ...+3.06+2.66%
TSROTESARO Inc-0.34-0.34%
IONSIonis Pharmaceutical...+1.07+3.01%
Data as of 4:15pm ET, 09/30/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)$0.81
Annual revenue (last year)$3.3B
Annual profit (last year)-$1.5B
Net profit margin-9.18%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul V. Campanelli
SVP-Operations, Research &
Development Strategy
Robert J. Cobuzzi
Corporate headquarters
Dublin, Dublin

Forecasts

Search for Jobs